Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium

BACKGROUND: HIV-associated neurocognitive disorder (HAND) remains highly prevalent despite effective anti-retroviral therapy (ART). A number of adjunctive pharmacotherapies for HAND have been studied with disappointing results, but preliminary data suggest that lithium may provide clinical benefit....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Decloedt, Eric H., Freeman, Carla, Howells, Fleur, Casson-Crook, Martine, Lesosky, Maia, Koutsilieri, Eleni, Lovestone, Simon, Maartens, Gary, Joska, John A.
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2016
Matèries:
4850
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5120936/
https://ncbi.nlm.nih.gov/pubmed/27861379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005401
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars